| pubmed-article:17705565 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17705565 | lifeskim:mentions | umls-concept:C0041755 | lld:lifeskim |
| pubmed-article:17705565 | lifeskim:mentions | umls-concept:C1314792 | lld:lifeskim |
| pubmed-article:17705565 | lifeskim:mentions | umls-concept:C0033204 | lld:lifeskim |
| pubmed-article:17705565 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:17705565 | lifeskim:mentions | umls-concept:C0175659 | lld:lifeskim |
| pubmed-article:17705565 | lifeskim:mentions | umls-concept:C0349674 | lld:lifeskim |
| pubmed-article:17705565 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:17705565 | lifeskim:mentions | umls-concept:C0222045 | lld:lifeskim |
| pubmed-article:17705565 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17705565 | pubmed:dateCreated | 2007-8-20 | lld:pubmed |
| pubmed-article:17705565 | pubmed:abstractText | Carbamazepine hypersensitivity syndrome is a rare, life-threatening condition. Its diagnosis is critical to avoid future exposure to aromatic anticonvulsants. Pediatricians rarely use a systematic approach to establish the cause of drug reactions in the clinical setting. We describe the use of the Naranjo adverse drug reaction probability scale to establish causality in three cases of suspected anticonvulsant hypersensitivity syndrome with the aim of introducing clinicians to this effective tool. Our analysis reveals that this method is useful, but also highlights potential areas for its improvement. | lld:pubmed |
| pubmed-article:17705565 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17705565 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17705565 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17705565 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17705565 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17705565 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17705565 | pubmed:issn | 1174-5878 | lld:pubmed |
| pubmed-article:17705565 | pubmed:author | pubmed-author:KorenGideonG | lld:pubmed |
| pubmed-article:17705565 | pubmed:author | pubmed-author:FinkelsteinYa... | lld:pubmed |
| pubmed-article:17705565 | pubmed:author | pubmed-author:AvnerMarinaM | lld:pubmed |
| pubmed-article:17705565 | pubmed:author | pubmed-author:HackamDanD | lld:pubmed |
| pubmed-article:17705565 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17705565 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:17705565 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17705565 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17705565 | pubmed:pagination | 267-70 | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:meshHeading | pubmed-meshheading:17705565... | lld:pubmed |
| pubmed-article:17705565 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17705565 | pubmed:articleTitle | Establishing causality in pediatric adverse drug reactions: use of the Naranjo probability scale. | lld:pubmed |
| pubmed-article:17705565 | pubmed:affiliation | Division of Clinical Pharmacology/Toxicology, The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada. | lld:pubmed |
| pubmed-article:17705565 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17705565 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:17705565 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
